CATHERINE RENKEN: Open Payments
NPI 1295432987 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 13 payments from 7 companies in 2025. Trend: 2023 $394 · 2024 $552 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $87 |
| Astellas Pharma US Inc | 2 | $55 |
| Novo Nordisk Inc | 2 | $52 |
| Seqirus USA Inc | 2 | $33 |
| Lilly USA, LLC | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: NURTEC ODT, Veozah, Wegovy, MOUNJARO, VOQUEZNA, PAXLOVID, Fluad, Flucelvax.
Industry payments across MD — which companies pay providers there.
